Peter Lio, MD - August 11, 2022 - The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis

DermDocs

Peter Lio, MD, LiVDerm faculty and atopic dermatitis expert, shares pearls from his session at the SBS 2022 event regarding the efficacy and safety of IL-13 inhibitors for treatment of AD.

  • What factors should clinicians consider when selecting a biologic or systemic therapy to manage atopic dermatitis?
  • Effectively and promptly diagnosing atopic dermatitis can be a bit tricky at times. What is your personal approach for effective diagnosis?
  • Which patients would benefit most from an integrative approach to managing atopic dermatitis?
  • How can clinicians execute effective shared decision-making strategies in the management of chronic skin conditions?

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada